$CHRS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Coherus BioSciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Coherus BioSciences, Inc.. Get notifications about new insider transactions in Coherus BioSciences, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 17 2020 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 20.08 | 2,798 | 56,186 | 46,841 | 49.6 K to 46.8 K (-5.64 %) |
Jan 17 2020 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 19.67 | 3,520 | 69,238 | 49,639 | 53.2 K to 49.6 K (-6.62 %) |
Jan 17 2020 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 10.05 | 6,318 | 63,496 | 53,159 | 46.8 K to 53.2 K (+13.49 %) |
Jan 14 2020 | CHRS | Coherus BioScience ... | Satvat Ali J. | Director | Option Exercise | A | 17.73 | 20,000 | 354,600 | 20,000 | |
Jan 14 2020 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Option Exercise | A | 17.73 | 20,000 | 354,600 | 20,000 | |
Jan 14 2020 | CHRS | Coherus BioScience ... | Wahlstrom Mats | Director | Option Exercise | A | 17.73 | 20,000 | 354,600 | 20,000 | |
Jan 14 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | A | 17.73 | 20,000 | 354,600 | 20,000 | |
Jan 14 2020 | CHRS | Coherus BioScience ... | LAWLIS V BRYAN | Director | Option Exercise | A | 17.73 | 20,000 | 354,600 | 20,000 | |
Jan 14 2020 | CHRS | Coherus BioScience ... | Richards Christos | Director | Option Exercise | A | 17.73 | 20,000 | 354,600 | 20,000 | |
Jan 14 2020 | CHRS | Coherus BioScience ... | NUSSBAUM SAMUEL R MD | Director | Option Exercise | A | 17.73 | 20,000 | 354,600 | 20,000 | |
Jan 14 2020 | CHRS | Coherus BioScience ... | Lanfear Dennis M | President & CEO | Option Exercise | A | 17.73 | 500,000 | 8,865,000 | 500,000 | |
Jan 14 2020 | CHRS | Coherus BioScience ... | Lanfear Dennis M | President & CEO | Payment of Exercise | F | 17.73 | 21,516 | 381,479 | 163,264 | 184.8 K to 163.3 K (-11.64 %) |
Jan 14 2020 | CHRS | Coherus BioScience ... | Lanfear Dennis M | President & CEO | Grant | A | 0.00 | 59,763 | 0 | 184,780 | 125 K to 184.8 K (+47.80 %) |
Jan 14 2020 | CHRS | Coherus BioScience ... | Vexler Vladimir | Chief Scientific Of ... | Option Exercise | A | 17.73 | 62,500 | 1,108,125 | 62,500 | |
Jan 14 2020 | CHRS | Coherus BioScience ... | Vexler Vladimir | Chief Scientific Of ... | Grant | A | 0.00 | 31,250 | 0 | 56,185 | 24.9 K to 56.2 K (+125.33 %) |
Jan 14 2020 | CHRS | Coherus BioScience ... | Vexler Vladimir | Chief Scientific Of ... | Payment of Exercise | F | 17.73 | 3,477 | 61,647 | 24,935 | 28.4 K to 24.9 K (-12.24 %) |
Jan 14 2020 | CHRS | Coherus BioScience ... | Vexler Vladimir | Chief Scientific Of ... | Grant | A | 0.00 | 8,900 | 0 | 28,412 | 19.5 K to 28.4 K (+45.61 %) |
Jan 14 2020 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | A | 17.73 | 62,500 | 1,108,125 | 62,500 | |
Jan 14 2020 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Grant | A | 0.00 | 31,250 | 0 | 46,841 | 15.6 K to 46.8 K (+200.44 %) |
Jan 14 2020 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Payment of Exercise | F | 17.73 | 7,077 | 125,475 | 15,591 | 22.7 K to 15.6 K (-31.22 %) |
Jan 14 2020 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Grant | A | 0.00 | 19,365 | 0 | 22,668 | 3.3 K to 22.7 K (+586.29 %) |
Jan 14 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | A | 17.73 | 62,500 | 1,108,125 | 62,500 | |
Jan 14 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Grant | A | 0.00 | 31,250 | 0 | 62,996 | 31.7 K to 63 K (+98.44 %) |
Jan 14 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Payment of Exercise | F | 17.73 | 7,146 | 126,699 | 31,746 | 38.9 K to 31.7 K (-18.37 %) |
Jan 14 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Grant | A | 0.00 | 19,566 | 0 | 38,892 | 19.3 K to 38.9 K (+101.24 %) |
Jan 13 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | M | 12.37 | 20,000 | 247,400 | 0 | |
Jan 13 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | M | 10.05 | 20,000 | 201,000 | 0 | |
Jan 13 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | M | 1.67 | 29,994 | 50,000 | 0 | |
Jan 13 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | M | 12.37 | 20,000 | 247,400 | 70,086 | 50.1 K to 70.1 K (+39.93 %) |
Jan 13 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | M | 10.05 | 20,000 | 201,000 | 50,086 | 30.1 K to 50.1 K (+66.48 %) |
Jan 13 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | M | 1.67 | 29,994 | 50,000 | 30,086 | 92 to 30.1 K (+32,602.17 %) |
Dec 18 2019 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 2.50 | 2,500 | 6,251 | 34,988 | |
Dec 18 2019 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 18.69 | 2,500 | 46,725 | 19,326 | 21.8 K to 19.3 K (-11.45 %) |
Dec 18 2019 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 2.50 | 2,500 | 6,251 | 21,826 | 19.3 K to 21.8 K (+12.94 %) |
Nov 25 2019 | CHRS | Coherus BioScience ... | Lanfear Dennis M | President & CEO | Sell | S | 18.56 | 12,500 | 231,960 | 446,684 | 459.2 K to 446.7 K (-2.72 %) |
Nov 22 2019 | CHRS | Coherus BioScience ... | Lanfear Dennis M | President & CEO | Sell | S | 18.00 | 825,000 | 14,850,000 | 459,184 | 1.3 M to 459.2 K (-64.24 %) |
Nov 22 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 10.05 | 3,159 | 31,748 | 111,046 | |
Nov 22 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 19.59 | 3,159 | 61,872 | 3,303 | 6.5 K to 3.3 K (-48.89 %) |
Nov 22 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 10.05 | 3,159 | 31,748 | 6,462 | 3.3 K to 6.5 K (+95.64 %) |
Nov 20 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 18.88 | 3,112 | 58,757 | 3,303 | 6.4 K to 3.3 K (-48.51 %) |
Nov 18 2019 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 2.50 | 2,500 | 6,251 | 37,488 | |
Nov 18 2019 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 19.26 | 2,500 | 48,150 | 19,310 | 21.8 K to 19.3 K (-11.46 %) |
Nov 18 2019 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 2.50 | 2,500 | 6,251 | 21,810 | 19.3 K to 21.8 K (+12.95 %) |
Oct 22 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 19.02 | 1,388 | 26,400 | 6,385 | 7.8 K to 6.4 K (-17.86 %) |
Oct 18 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 10.05 | 3,159 | 31,748 | 114,205 | |
Oct 18 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 19.00 | 3,159 | 60,021 | 7,773 | 10.9 K to 7.8 K (-28.90 %) |
Oct 18 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 10.05 | 3,159 | 31,748 | 10,932 | 7.8 K to 10.9 K (+40.64 %) |
Oct 16 2019 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 2.50 | 2,500 | 6,251 | 39,988 | |
Oct 16 2019 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 18.40 | 2,500 | 46,000 | 19,310 | 21.8 K to 19.3 K (-11.46 %) |
Oct 16 2019 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 2.50 | 2,500 | 6,251 | 21,810 | 19.3 K to 21.8 K (+12.95 %) |
Sep 25 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 21.78 | 740 | 16,117 | 7,773 | 8.5 K to 7.8 K (-8.69 %) |
Sep 20 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 10.05 | 3,159 | 31,748 | 117,364 | |
Sep 20 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 20.44 | 3,159 | 64,560 | 8,513 | 11.7 K to 8.5 K (-27.06 %) |
Sep 20 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 10.05 | 3,159 | 31,748 | 11,672 | 8.5 K to 11.7 K (+37.11 %) |
Sep 18 2019 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 2.50 | 2,500 | 6,251 | 42,488 | |
Sep 18 2019 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 20.03 | 2,500 | 50,075 | 19,310 | 21.8 K to 19.3 K (-11.46 %) |
Sep 18 2019 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 2.50 | 2,500 | 6,251 | 21,810 | 19.3 K to 21.8 K (+12.95 %) |
Aug 23 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 10.05 | 6,318 | 63,496 | 120,523 | |
Aug 23 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 21.75 | 6,058 | 131,766 | 8,513 | 14.6 K to 8.5 K (-41.58 %) |
Aug 23 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 20.73 | 260 | 5,389 | 14,571 | 14.8 K to 14.6 K (-1.75 %) |
Aug 23 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 10.05 | 6,318 | 63,496 | 14,831 | 8.5 K to 14.8 K (+74.22 %) |
Aug 21 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 19.04 | 3,000 | 57,120 | 8,513 | 11.5 K to 8.5 K (-26.06 %) |
Aug 16 2019 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 2.50 | 2,500 | 6,251 | 44,988 | |
Aug 16 2019 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 19.00 | 2,500 | 47,500 | 19,310 | 21.8 K to 19.3 K (-11.46 %) |
Aug 16 2019 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 2.50 | 2,500 | 6,251 | 21,810 | 19.3 K to 21.8 K (+12.95 %) |
Jul 17 2019 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 2.50 | 2,500 | 6,251 | 47,488 | |
Jul 17 2019 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 19.20 | 2,500 | 48,000 | 19,310 | 21.8 K to 19.3 K (-11.46 %) |
Jul 17 2019 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 2.50 | 2,500 | 6,251 | 21,810 | 19.3 K to 21.8 K (+12.95 %) |
Jul 02 2019 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Sell | S | 22.61 | 160,000 | 3,617,600 | 1,933,221 | 2.1 M to 1.9 M (-7.64 %) |
Jul 02 2019 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Sell | S | 22.05 | 200,000 | 4,410,000 | 2,093,221 | 2.3 M to 2.1 M (-8.72 %) |
Jun 24 2019 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Sell | S | 21.37 | 317,130 | 6,777,068 | 2,293,221 | 2.6 M to 2.3 M (-12.15 %) |
Jun 20 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 10.05 | 3,159 | 31,748 | 126,841 | |
Jun 20 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 20.81 | 100 | 2,081 | 11,513 | 11.6 K to 11.5 K (-0.86 %) |
Jun 20 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 20.32 | 3,059 | 62,166 | 11,613 | 14.7 K to 11.6 K (-20.85 %) |
Jun 20 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 10.05 | 3,159 | 31,748 | 14,672 | 11.5 K to 14.7 K (+27.44 %) |
Jun 20 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 20.00 | 667 | 13,340 | 11,513 | 12.2 K to 11.5 K (-5.48 %) |
Jun 20 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 19.31 | 3,000 | 57,926 | 12,180 | 15.2 K to 12.2 K (-19.76 %) |
Jun 04 2019 | CHRS | Coherus BioScience ... | Wahlstrom Mats | Director | Buy | J | 0.00 | 98,152 | 0 | 318,066 | 219.9 K to 318.1 K (+44.63 %) |
Jun 04 2019 | CHRS | Coherus BioScience ... | Wahlstrom Mats | Director | Sell | J | 0.00 | 178,528 | 0 | 0 | 178.5 K to 0 (-100.00 %) |
May 31 2019 | CHRS | Coherus BioScience ... | Lanfear Dennis M | President & CEO | Sell | S | 19.49 | 32,398 | 631,282 | 1,284,184 | 1.3 M to 1.3 M (-2.46 %) |
May 31 2019 | CHRS | Coherus BioScience ... | Lanfear Dennis M | President & CEO | Sell | S | 19.49 | 32,398 | 631,282 | 1,284,184 | 1.3 M to 1.3 M (-2.46 %) |
May 24 2019 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Sell | S | 20.69 | 257,870 | 5,335,330 | 2,610,351 | 2.9 M to 2.6 M (-8.99 %) |
Mar 22 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 14.92 | 3,000 | 44,762 | 13,185 | 16.2 K to 13.2 K (-18.54 %) |
Jan 30 2019 | CHRS | Coherus BioScience ... | Satvat Ali J. | Director | Option Exercise | A | 12.37 | 20,000 | 247,400 | 20,000 | |
Jan 30 2019 | CHRS | Coherus BioScience ... | LAWLIS V BRYAN | Director | Option Exercise | A | 12.37 | 20,000 | 247,400 | 20,000 | |
Jan 30 2019 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Option Exercise | A | 12.37 | 20,000 | 247,400 | 20,000 | |
Jan 30 2019 | CHRS | Coherus BioScience ... | NUSSBAUM SAMUEL R MD | Director | Option Exercise | A | 12.37 | 20,000 | 247,400 | 20,000 | |
Jan 30 2019 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | A | 12.37 | 20,000 | 247,400 | 20,000 | |
Jan 30 2019 | CHRS | Coherus BioScience ... | Wahlstrom Mats | Director | Option Exercise | A | 12.37 | 20,000 | 247,400 | 20,000 | |
Jan 30 2019 | CHRS | Coherus BioScience ... | Richards Christos | Director | Option Exercise | A | 12.37 | 20,000 | 247,400 | 20,000 | |
Jan 15 2019 | CHRS | Coherus BioScience ... | Lanfear Dennis M | President and CEO | Option Exercise | A | 12.37 | 450,000 | 5,566,500 | 450,000 | |
Jan 15 2019 | CHRS | Coherus BioScience ... | Lanfear Dennis M | President and CEO | Payment of Exercise | F | 12.37 | 17,867 | 221,015 | 125,017 | 142.9 K to 125 K (-12.50 %) |
Jan 15 2019 | CHRS | Coherus BioScience ... | Lanfear Dennis M | President and CEO | Grant | A | 0.00 | 50,265 | 0 | 142,884 | 92.6 K to 142.9 K (+54.27 %) |
Jan 15 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | A | 12.37 | 126,000 | 1,558,620 | 126,000 | |
Jan 15 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Payment of Exercise | F | 12.37 | 6,297 | 77,894 | 16,185 | 22.5 K to 16.2 K (-28.01 %) |
Jan 15 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Grant | A | 0.00 | 16,685 | 0 | 22,482 | 5.8 K to 22.5 K (+287.82 %) |
Jan 15 2019 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | A | 12.37 | 126,000 | 1,558,620 | 126,000 | |
Jan 15 2019 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Payment of Exercise | F | 12.37 | 6,404 | 79,217 | 17,295 | 23.7 K to 17.3 K (-27.02 %) |
Jan 15 2019 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Grant | A | 0.00 | 16,997 | 0 | 23,699 | 6.7 K to 23.7 K (+253.61 %) |
Jan 15 2019 | CHRS | Coherus BioScience ... | Vexler Vladimir | Chief Scientific Of ... | Option Exercise | A | 12.37 | 126,000 | 1,558,620 | 126,000 | |
Jan 15 2019 | CHRS | Coherus BioScience ... | Vexler Vladimir | Chief Scientific Of ... | Payment of Exercise | F | 12.37 | 5,916 | 73,181 | 17,474 | 23.4 K to 17.5 K (-25.29 %) |
Jan 15 2019 | CHRS | Coherus BioScience ... | Vexler Vladimir | Chief Scientific Of ... | Grant | A | 0.00 | 15,562 | 0 | 23,390 | 7.8 K to 23.4 K (+198.80 %) |
Nov 20 2018 | CHRS | Coherus BioScience ... | Vexler Vladimir | Chief Scientific Of ... | Option Exercise | A | 12.27 | 35,000 | 429,450 | 35,000 | |
Sep 25 2018 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 13.50 | 740 | 9,990 | 111,741 | |
Sep 25 2018 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 13.50 | 740 | 9,990 | 4,519 | 3.8 K to 4.5 K (+19.58 %) |
Sep 12 2018 | CHRS | Coherus BioScience ... | FINCK BARBARA K | Chief Medical Offic ... | Option Exercise | M | 1.42 | 1,760 | 2,499 | 82,941 | |
Sep 12 2018 | CHRS | Coherus BioScience ... | FINCK BARBARA K | Chief Medical Offic ... | Sell | S | 18.58 | 1,760 | 32,699 | 37,043 | 38.8 K to 37 K (-4.54 %) |
Sep 12 2018 | CHRS | Coherus BioScience ... | FINCK BARBARA K | Chief Medical Offic ... | Buy | M | 1.42 | 1,760 | 2,499 | 38,803 | 37 K to 38.8 K (+4.75 %) |
Aug 31 2018 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Sell | S | 20.50 | 25,000 | 512,500 | 2,868,221 | 2.9 M to 2.9 M (-0.86 %) |
Aug 15 2018 | CHRS | Coherus BioScience ... | FINCK BARBARA K | Chief Medical Offic ... | Option Exercise | M | 1.42 | 1,760 | 2,499 | 84,701 | |
Aug 15 2018 | CHRS | Coherus BioScience ... | FINCK BARBARA K | Chief Medical Offic ... | Sell | S | 19.02 | 1,760 | 33,480 | 37,043 | 38.8 K to 37 K (-4.54 %) |
Aug 15 2018 | CHRS | Coherus BioScience ... | FINCK BARBARA K | Chief Medical Offic ... | Buy | M | 1.42 | 1,760 | 2,499 | 38,803 | 37 K to 38.8 K (+4.75 %) |
Jul 25 2018 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 18.56 | 9,291 | 172,472 | 3,779 | 13.1 K to 3.8 K (-71.09 %) |
Jul 11 2018 | CHRS | Coherus BioScience ... | FINCK BARBARA K | Chief Medical Offic ... | Option Exercise | M | 1.42 | 1,260 | 1,789 | 86,461 | |
Jul 11 2018 | CHRS | Coherus BioScience ... | FINCK BARBARA K | Chief Medical Offic ... | Option Exercise | M | 1.42 | 500 | 710 | 87,721 | |
Jul 11 2018 | CHRS | Coherus BioScience ... | FINCK BARBARA K | Chief Medical Offic ... | Sell | S | 15.00 | 1,260 | 18,900 | 37,043 | 38.3 K to 37 K (-3.29 %) |
Jul 11 2018 | CHRS | Coherus BioScience ... | FINCK BARBARA K | Chief Medical Offic ... | Buy | M | 1.42 | 1,260 | 1,789 | 38,303 | 37 K to 38.3 K (+3.40 %) |
Jul 11 2018 | CHRS | Coherus BioScience ... | FINCK BARBARA K | Chief Medical Offic ... | Sell | S | 15.03 | 500 | 7,515 | 37,043 | 37.5 K to 37 K (-1.33 %) |
Jul 11 2018 | CHRS | Coherus BioScience ... | FINCK BARBARA K | Chief Medical Offic ... | Buy | M | 1.42 | 500 | 710 | 37,543 | 37 K to 37.5 K (+1.35 %) |
Jun 20 2018 | CHRS | Coherus BioScience ... | FINCK BARBARA K | Chief Medical Offic ... | Option Exercise | M | 1.42 | 1,760 | 2,499 | 88,221 | |
Jun 20 2018 | CHRS | Coherus BioScience ... | FINCK BARBARA K | Chief Medical Offic ... | Sell | S | 15.00 | 1,760 | 26,400 | 37,043 | 38.8 K to 37 K (-4.54 %) |
Jun 20 2018 | CHRS | Coherus BioScience ... | FINCK BARBARA K | Chief Medical Offic ... | Buy | M | 1.42 | 1,760 | 2,499 | 38,803 | 37 K to 38.8 K (+4.75 %) |
May 17 2018 | CHRS | Coherus BioScience ... | Lanfear Dennis M | See Remarks | Sell | S | 16.26 | 20,984 | 341,265 | 1,316,582 | 1.3 M to 1.3 M (-1.57 %) |
May 16 2018 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | A | 16.75 | 50,000 | 837,500 | 50,000 | |
May 11 2018 | CHRS | Coherus BioScience ... | NUSSBAUM SAMUEL R MD | Director | Option Exercise | A | 15.60 | 40,000 | 624,000 | 40,000 | |
Mar 05 2018 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief, Quality & Co ... | Option Exercise | A | 9.80 | 25,000 | 245,000 | 25,000 | |
Feb 05 2018 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | A | 10.05 | 20,000 | 201,000 | 20,000 | |
Feb 05 2018 | CHRS | Coherus BioScience ... | LAWLIS V BRYAN | Director | Option Exercise | A | 10.05 | 20,000 | 201,000 | 20,000 | |
Feb 05 2018 | CHRS | Coherus BioScience ... | Watler Peter K. | Chief Technical Off ... | Option Exercise | A | 10.05 | 50,000 | 502,500 | 50,000 | |
Feb 05 2018 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Option Exercise | A | 10.05 | 20,000 | 201,000 | 20,000 | |
Feb 05 2018 | CHRS | Coherus BioScience ... | Satvat Ali J. | Director | Option Exercise | A | 10.05 | 20,000 | 201,000 | 20,000 | |
Feb 05 2018 | CHRS | Coherus BioScience ... | FINCK BARBARA K | Chief Medical Offic ... | Option Exercise | A | 10.05 | 130,000 | 1,306,500 | 130,000 | |
Feb 05 2018 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | A | 10.05 | 130,000 | 1,306,500 | 130,000 | |
Feb 05 2018 | CHRS | Coherus BioScience ... | Lanfear Dennis M | See Remarks | Option Exercise | A | 10.05 | 400,000 | 4,020,000 | 400,000 | |
Feb 05 2018 | CHRS | Coherus BioScience ... | Wahlstrom Mats | Director | Option Exercise | A | 10.05 | 20,000 | 201,000 | 20,000 | |
Feb 05 2018 | CHRS | Coherus BioScience ... | Richards Christos | Director | Option Exercise | A | 10.05 | 20,000 | 201,000 | 20,000 | |
Dec 19 2017 | CHRS | Coherus BioScience ... | Herman Alan C. | Chief Scientific Of ... | Grant | A | 0.00 | 809 | 0 | 50,460 | 49.7 K to 50.5 K (+1.63 %) |
Dec 19 2017 | CHRS | Coherus BioScience ... | FINCK BARBARA K | Chief Medical Offic ... | Grant | A | 0.00 | 7,545 | 0 | 34,336 | 26.8 K to 34.3 K (+28.16 %) |
Dec 19 2017 | CHRS | Coherus BioScience ... | Watler Peter K. | Chief Technical Off ... | Grant | A | 0.00 | 5,900 | 0 | 5,900 | 0 to 5.9 K |
Dec 19 2017 | CHRS | Coherus BioScience ... | Lanfear Dennis M | See Remarks | Grant | A | 0.00 | 20,984 | 0 | 92,619 | 71.6 K to 92.6 K (+29.29 %) |
Dec 19 2017 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Grant | A | 0.00 | 6,966 | 0 | 9,958 | 3 K to 10 K (+232.82 %) |
Aug 10 2017 | CHRS | Coherus BioScience ... | Herman Alan C. | Chief Scientific Of ... | Sell | S | 15.02 | 17,535 | 263,300 | 49,651 | 67.2 K to 49.7 K (-26.10 %) |
Aug 08 2017 | CHRS | Coherus BioScience ... | Watler Peter K. | Chief Technical Off ... | Option Exercise | A | 12.70 | 67,000 | 850,900 | 67,000 | |
Aug 08 2017 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | A | 12.70 | 67,000 | 850,900 | 67,000 | |
Aug 08 2017 | CHRS | Coherus BioScience ... | FINCK BARBARA K | Chief Medical Offic ... | Option Exercise | A | 12.70 | 67,000 | 850,900 | 67,000 | |
Aug 08 2017 | CHRS | Coherus BioScience ... | Lanfear Dennis M | President and CEO | Option Exercise | A | 12.70 | 200,000 | 2,540,000 | 200,000 | |
Jul 07 2017 | CHRS | Coherus BioScience ... | Herman Alan C. | Chief Scientific Of ... | Sell | S | 15.00 | 600 | 9,000 | 67,186 | 67.8 K to 67.2 K (-0.89 %) |
Jun 05 2017 | CHRS | Coherus BioScience ... | Herman Alan C. | Chief Scientific Of ... | Sell | S | 20.98 | 1,732 | 36,342 | 67,786 | 69.5 K to 67.8 K (-2.49 %) |
Jun 05 2017 | CHRS | Coherus BioScience ... | Herman Alan C. | Chief Scientific Of ... | Sell | S | 20.20 | 9,601 | 193,950 | 69,518 | 79.1 K to 69.5 K (-12.13 %) |
May 19 2017 | CHRS | Coherus BioScience ... | Satvat Ali J. | Director | Option Exercise | A | 23.80 | 20,000 | 476,000 | 20,000 |